Literature DB >> 10906193

Definition of five new simian immunodeficiency virus cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I molecules: evidence for an influence on disease progression.

D T Evans1, P Jing, T M Allen, D H O'Connor, H Horton, J E Venham, M Piekarczyk, J Dzuris, M Dykhuzen, J Mitchen, R A Rudersdorf, C D Pauza, A Sette, R E Bontrop, R DeMars, D I Watkins.   

Abstract

Simian immunodeficiency virus (SIV) infection of the rhesus macaque is currently the best animal model for AIDS vaccine development. One limitation of this model, however, has been the small number of cytotoxic T-lymphocyte (CTL) epitopes and restricting major histocompatibility complex (MHC) class I molecules available for investigating virus-specific CTL responses. To identify new MHC class I-restricted CTL epitopes, we infected five members of a family of MHC-defined rhesus macaques intravenously with SIV. Five new CTL epitopes bound by four different MHC class I molecules were defined. These included two Env epitopes bound by Mamu-A*11 and -B*03 and three Nef epitopes bound by Mamu-B*03, -B*04, and -B*17. All four restricting MHC class I molecules were encoded on only two haplotypes (b or c). Interestingly, resistance to disease progression within this family appeared to be associated with the inheritance of one or both of these MHC class I haplotypes. Two individuals that inherited haplotypes b and c separately survived for 299 and 511 days, respectively, while another individual that inherited both haplotypes survived for 889 days. In contrast, two MHC class I-identical individuals that did not inherit either haplotype rapidly progressed to disease (survived <80 days). Since all five offspring were identical at their Mamu-DRB loci, MHC class II differences are unlikely to account for their patterns of disease progression. These results double the number of SIV CTL epitopes defined in rhesus macaques and provide evidence that allelic differences at the MHC class I loci may influence rates of disease progression among AIDS virus-infected individuals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10906193      PMCID: PMC112260          DOI: 10.1128/jvi.74.16.7400-7410.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Mhc-DQB repertoire variation in hominoid and Old World primate species.

Authors:  N Otting; M Kenter; P van Weeren; M Jonker; R E Bontrop
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

2.  Transfer of cloned human class I major histocompatibility complex genes into HLA mutant human lymphoblastoid cells.

Authors:  Y Shimizu; B Koller; D Geraghty; H Orr; S Shaw; P Kavathas; R DeMars
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

3.  Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

Authors:  D T Evans; D H O'Connor; P Jing; J L Dzuris; J Sidney; J da Silva; T M Allen; H Horton; J E Venham; R A Rudersdorf; T Vogel; C D Pauza; R E Bontrop; R DeMars; A Sette; A L Hughes; D I Watkins
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

4.  Presentation of an immunodominant T-cell epitope of hepatitis B surface antigen by the HLA-DPw4 molecule.

Authors:  E Celis; R W Karr
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

5.  Major histocompatibility complex class I molecules of nonhuman primates.

Authors:  D I Watkins; M Kannagi; M E Stone; N L Letvin
Journal:  Eur J Immunol       Date:  1988-09       Impact factor: 5.532

6.  SB-restricted presentation of influenza and herpes simplex virus antigens to human T-lymphocyte clones.

Authors:  D D Eckels; P Lake; J R Lamb; A H Johnson; S Shaw; J N Woody; R J Hartzman
Journal:  Nature       Date:  1983-02-24       Impact factor: 49.962

7.  Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys.

Authors:  M D Miller; H Yamamoto; A L Hughes; D I Watkins; N L Letvin
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

8.  Evolutionary relationships among the primate Mhc-DQA1 and DQA2 alleles.

Authors:  M Kenter; N Otting; J Anholts; J Leunissen; M Jonker; R E Bontrop
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

9.  Conserved MHC class I peptide binding motif between humans and rhesus macaques.

Authors:  J L Dzuris; J Sidney; E Appella; R W Chesnut; D I Watkins; A Sette
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

10.  HLA-B35 is associated with accelerated progression to AIDS.

Authors:  S Itescu; U Mathur-Wagh; M L Skovron; L J Brancato; M Marmor; A Zeleniuch-Jacquotte; R Winchester
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992
View more
  36 in total

1.  Emergence and kinetics of simian immunodeficiency virus-specific CD8(+) T cells in the intestines of macaques during primary infection.

Authors:  R S Veazey; M C Gauduin; K G Mansfield; I C Tham; J D Altman; J D Lifson; A A Lackner; R P Johnson
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?

Authors:  Thorsten U Vogel; Thomas C Friedrich; David H O'Connor; William Rehrauer; Elizabeth J Dodds; Heather Hickman; William Hildebrand; John Sidney; Alessandro Sette; Austin Hughes; Helen Horton; Kathy Vielhuber; Richard Rudersdorf; Ivna P De Souza; Matthew R Reynolds; Todd M Allen; Nancy Wilson; David I Watkins
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Transcriptionally abundant major histocompatibility complex class I alleles are fundamental to nonhuman primate simian immunodeficiency virus-specific CD8+ T cell responses.

Authors:  Melisa L Budde; Jennifer J Lhost; Benjamin J Burwitz; Ericka A Becker; Charles M Burns; Shelby L O'Connor; Julie A Karl; Roger W Wiseman; Benjamin N Bimber; Guang Lan Zhang; William Hildebrand; Vladimir Brusic; David H O'Connor
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

4.  CD8+ T cell escape mutations in simian immunodeficiency virus SIVmac239 cause fitness defects in vivo, and many revert after transmission.

Authors:  Philip A Mudd; Adam J Ericsen; Andrew D Walsh; Enrique J León; Nancy A Wilson; Nicholas J Maness; Thomas C Friedrich; David I Watkins
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

5.  Viral vectored granulocyte-macrophage colony stimulating factor inhibits vaccine protection in an SIV challenge model: protection correlates with neutralizing antibody.

Authors:  John B Schell; Kapil Bahl; Nina F Rose; Linda Buonocore; Meredith Hunter; Preston A Marx; Celia C LaBranche; David C Montefiori; John K Rose
Journal:  Vaccine       Date:  2012-04-23       Impact factor: 3.641

6.  The locus encoding an oligomorphic family of MHC-A alleles (Mane-A*06/Mamu-A*05) is present at high frequency in several macaque species.

Authors:  Bernard A P Lafont; Christopher M McGraw; Sabriya A Stukes; Alicia Buckler-White; Ronald J Plishka; Russell A Byrum; Vanessa M Hirsch; Malcolm A Martin
Journal:  Immunogenetics       Date:  2007-01-26       Impact factor: 2.846

7.  Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity.

Authors:  Alessandro Sette; John Sidney; Huynh-Hoa Bui; Marie-France del Guercio; Jeff Alexander; John Loffredo; David I Watkins; Bianca R Mothé
Journal:  Immunogenetics       Date:  2005-03-04       Impact factor: 2.846

8.  Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules.

Authors:  J L Dzuris; J Sidney; H Horton; R Correa; D Carter; R W Chesnut; D I Watkins; A Sette
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Control of simian immunodeficiency virus SIVmac239 is not predicted by inheritance of Mamu-B*17-containing haplotypes.

Authors:  Jason A Wojcechowskyj; Levi J Yant; Roger W Wiseman; Shelby L O'Connor; David H O'Connor
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  Maintenance or emergence of chronic phase secondary cytotoxic T lymphocyte responses after loss of acute phase immunodominant responses does not protect SIV-infected rhesus macaques from disease progression.

Authors:  M Shannon Keckler; Vida L Hodara; Laura M Parodi; Luis D Giavedoni
Journal:  J Biomed Biotechnol       Date:  2010-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.